London-based smartphone maker Nothing is boosting investments in India, targeting Gen Zers in the world’s most-populous nation.

In the preliminary stages of crafting a business plan, conducting a thorough industry analysis is paramount to understanding ...

Google PM Ryan Salva is responsible for tools like Gemini CLI, giving him a front-row seat to the ways AI tools are changing ...

Java 25 LTS is officially here, and with it comes a massive update to IntelliJ IDEA. The new version is all about making the ...

Nintendo doesn't really need to create new franchises, a former developer has said, explaining that the company can simply wrap its fresh gameplay ideas into one of the many beloved video game series ...

BAY CITY, MI – A veteran-owned investment casting foundry in Bay City is poised for a major expansion, pending approval from the Bay City Commission. The commission will vote Monday, Sept. 8, on ...

The bidding process was questioned on Friday after the company, Public Partnerships LLC, admitted it had exchanged unspecified communications with state officials before the contract was awarded. By ...

WASHINGTON – The Republican-controlled House of Representatives voted on party lines on Aug. 3 to create a special panel to reinvestigate the events of the Jan. 6, 2021 insurrection. In 2022, after 18 ...

FedEx Corp. has launched a regional office in Riyadh and secured a Saudi economic license to operate as a foreign air carrier, deepening its bet on the kingdom as a rising logistics power in the ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

Shifting federal COVID-19 vaccine criteria are making seasonal vaccinations a more complicated process, both for patients and providers. Retail pharmacies are often the most convenient places for ...